NCT01879293View on ClinicalTrials.gov

Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Left Ventriclar Mass
Interventions
DRUG

Metformin

DRUG

placebo

Trial Locations (1)

430070

Wuhan General Hospital, Wuhan

All Listed Sponsors
lead

Wuhan General Hospital of Guangzhou Military Command

OTHER

NCT01879293 - Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease | Biotech Hunter | Biotech Hunter